Principal Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-4,238
Closed -$1.21M – 2465
2020
Q3
$1.21M Sell
4,238
-256
-6% -$60.2K ﹤0.01% 1826
2020
Q2
$846K Buy
4,494
+1,422
+46% +$231K ﹤0.01% 1859
2020
Q1
$378K Buy
3,072
+247
+9% +$38.6K ﹤0.01% 1915
2019
Q4
$468K Sell
2,825
-45
-2% -$7.48K ﹤0.01% 1964
2019
Q3
$351K Buy
2,870
+102
+4% +$13.5K ﹤0.01% 2024
2019
Q2
$343K Buy
2,768
+263
+10% +$33.4K ﹤0.01% 2036
2019
Q1
$331K Hold
2,505
– – ﹤0.01% 2016
2018
Q4
$351K Buy
+2,505
New +$332K ﹤0.01% 1990

Other funds holding ONC

Principal Financial Group's ONC Position: Q4 2020 in Review

Principal Financial Group sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 4,238 shares — an estimated $1.21M sold.

Principal Financial Group first reported a position in ONC in Q4 2018 and held it in 8 quarters. The position peaked at $1.21M in Q3 2020. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Principal Financial Group reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Principal Financial Group sold 4,238 BeOne Medicines Ltd shares in Q4 2020, an estimated $1.21M.
  • Principal Financial Group first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 8 quarters.
  • Principal Financial Group's BeOne Medicines Ltd position peaked at $1.21M in Q3 2020.
  • 248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Principal Financial Group's 13F filing for Q4 2020, filed 8 Feb 2021.